Mark J. Tarr - Aug 16, 2023 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: President & CEO, Director
Signature: /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr
Stock symbol: EHC
Transactions as of: Aug 16, 2023
Transactions value $: -$1,127,438
Form type: 4
Date filed: 8/17/2023, 08:44 PM
Previous filing: Mar 2, 2023
Next filing: Jan 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHC	Encompass Health Common Stock	Options Exercise	$673K	+25.3K	+5.09%	$26.55	523K	Aug 16, 2023	Direct
transaction	EHC	Encompass Health Common Stock	Sale	-$1.8M	-25.3K	-4.85%	$71.06	497K	Aug 16, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-25.3K	-100%	$0.00^*	0	Aug 16, 2023	Encompass Health Common Stock	25.3K	$26.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.00 to $71.23, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F2	The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

Content

This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.00 to $71.23, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.